Orexo: Zubsolv Rx data and CMD takeaways
Research Update
2018-12-07
12:23
Zubsolv sales continue to grow better than double-digit percentage points (+21% y/y in November). However, the market share ended the month slightly lower by 0.1% compared to October.
KP
Klas Palin
Disclosures and disclaimers